1. Home
  2. BOLD vs BRFH Comparison

BOLD vs BRFH Comparison

Compare BOLD & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • BRFH
  • Stock Information
  • Founded
  • BOLD 2018
  • BRFH 2005
  • Country
  • BOLD United States
  • BRFH United States
  • Employees
  • BOLD N/A
  • BRFH N/A
  • Industry
  • BOLD
  • BRFH Packaged Foods
  • Sector
  • BOLD
  • BRFH Consumer Staples
  • Exchange
  • BOLD Nasdaq
  • BRFH Nasdaq
  • Market Cap
  • BOLD 30.3M
  • BRFH 43.8M
  • IPO Year
  • BOLD 2024
  • BRFH N/A
  • Fundamental
  • Price
  • BOLD $1.50
  • BRFH $2.50
  • Analyst Decision
  • BOLD Hold
  • BRFH Strong Buy
  • Analyst Count
  • BOLD 1
  • BRFH 1
  • Target Price
  • BOLD N/A
  • BRFH $4.50
  • AVG Volume (30 Days)
  • BOLD 63.1K
  • BRFH 7.2K
  • Earning Date
  • BOLD 05-16-2025
  • BRFH 05-01-2025
  • Dividend Yield
  • BOLD N/A
  • BRFH N/A
  • EPS Growth
  • BOLD N/A
  • BRFH N/A
  • EPS
  • BOLD N/A
  • BRFH N/A
  • Revenue
  • BOLD N/A
  • BRFH $10,818,000.00
  • Revenue This Year
  • BOLD N/A
  • BRFH $41.20
  • Revenue Next Year
  • BOLD N/A
  • BRFH $42.03
  • P/E Ratio
  • BOLD N/A
  • BRFH N/A
  • Revenue Growth
  • BOLD N/A
  • BRFH 22.03
  • 52 Week Low
  • BOLD $1.06
  • BRFH $1.44
  • 52 Week High
  • BOLD $12.26
  • BRFH $4.61
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • BRFH 43.99
  • Support Level
  • BOLD N/A
  • BRFH $2.30
  • Resistance Level
  • BOLD N/A
  • BRFH $2.97
  • Average True Range (ATR)
  • BOLD 0.00
  • BRFH 0.18
  • MACD
  • BOLD 0.00
  • BRFH 0.02
  • Stochastic Oscillator
  • BOLD 0.00
  • BRFH 32.15

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

Share on Social Networks: